Premalignant SOX2 in ovarian cancer patients

• None DUO:0000001 (version: 2019-01-07)data use permissionA data item that is used to indicate consent permissions for datasets and/or materials, and relates to the purposes for which datasets and/or material might be removed, stored or used.
• RU DUO:0000014 (version: 2019-01-07)research use onlyThis data use limitation indicates that use is limited to research purposes (e.g., does not include its use in clinical care).
• PS DUO:0000027 (version: 2019-01-07)project specific restrictionThis data use modifier indicates that use is limited to use within an approved project.

Ovarian Cancer Lab, University of Oxford - DATA ACCESS POLICY

Ovarian Cancer Lab, University of Oxford DATA ACCESS POLICY 1. All data access request should be addressed to the Data Access Committee (DAC). 2. The requesters should provide a one-page application specifying: a. An outline of the proposed work. b. A description of where the data will be stored and the level of security that is provided to ensure the confidentiality of the data. 3. The DAC will grant access to the data only to accredited requesters whose data usage has been approved. 4. Once the request has been approved by the DAC, a Data Access Agreement will be put in place between the University of Oxford and the requester’s institute. 5. It is the requester responsibility to ensure that: a. The data will be used only for the specified purpose and only by the requesting party. b. The data will not be shared with third parties unless clearly approved by the DAC. c. Any publication based on the data must cite the following paper as the source of data. : “Premalignant SOX2 overexpression in the fallopian tubes of ovarian cancer patients: Discovery and validation studies “